- Home
- XLO vs AREN Comparison
XLO vs AREN Comparison
Compare XLO & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XLO | AREN |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8M | 53.3M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | XLO | AREN |
|---|---|---|
| Price | $9.15 | $0.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $28.00 | $8.00 |
| AVG Volume (30 Days) | 33.3K | ★ 182.6K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 191.93 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,766,000.00 | $16,892,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $168.77 | $5.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 589.88 | 27.46 |
| 52 Week Low | $0.46 | $0.81 |
| 52 Week High | $9.89 | $7.85 |
Technical Indicators
Market Signals| Indicator | XLO | AREN |
|---|---|---|
| Relative Strength Index (RSI) | 58.36 | 27.29 |
| Support Level | $7.47 | N/A |
| Resistance Level | N/A | $1.61 |
| Average True Range (ATR) | 0.54 | 0.14 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 59.42 | 3.39 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
About AREN The Arena Group Holdings Inc.
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The company has four reportable segments: Sports & Leisure, Finance, Lifestyle, and Platform & Other. The company generates revenue from Sports & Leisure. Geographically, the company operates in United States; and Others. It generates maximum revenue from United States.